Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CPSF3 Inhibitors

CPSF3 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of Cleavage and Polyadenylation Specificity Factor 3 (CPSF3), an essential component of the pre-mRNA processing machinery. CPSF3 plays a pivotal role in the cleavage of pre-mRNA, a crucial step in the formation of mature messenger RNA (mRNA). The inhibitors of CPSF3 are characterized by their ability to bind to and obstruct the active site of CPSF3, thereby hindering its function in the mRNA processing pathway. This interaction is critical as it directly affects the efficacy of mRNA maturation and subsequent protein synthesis. The molecular structure of CPSF3 inhibitors is often complex, incorporating specific functional groups that are strategically positioned to maximize binding affinity and specificity. These structures usually include various moieties that are designed to interact with key domains of CPSF3, such as the catalytic center or the substrate binding regions.

The development and study of CPSF3 inhibitors involve a combination of advanced techniques in chemical synthesis, structural biology, and computational modeling. Researchers utilize high-throughput screening methods to identify inhibitory molecules, followed by iterative chemical modifications to enhance their selectivity and potency against CPSF3. Structural analysis methods such as X-ray crystallography or NMR spectroscopy are employed to elucidate the molecular interactions between these inhibitors and CPSF3. This detailed understanding is crucial for refining the inhibitors' design, ensuring that they effectively target CPSF3's active site. Additionally, the physicochemical properties of CPSF3 inhibitors, such as solubility, stability, and molecular weight, are vital considerations in their development. These properties are meticulously optimized to ensure that the inhibitors effectively interact with CPSF3, thereby influencing the mRNA processing pathway. The intricate design and development of CPSF3 inhibitors demonstrate the importance of understanding and modulating molecular mechanisms at the cellular level.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide has been noted for its ability to inhibit general transcription, potentially affecting CPSF3 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin inhibits RNA polymerase II, which could reduce overall mRNA synthesis including that of CPSF3.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB inhibits RNA Pol II phosphorylation and may lower CPSF3 mRNA production.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol inhibits CDK9, a part of the P-TEFb complex, impacting transcription elongation and potentially CPSF3 expression.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin disrupts mRNA synthesis and processing, which might result in reduced expression of CPSF3.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 inhibits BET bromodomains, affecting the expression of certain genes, which may include CPSF3.

GSK 525762A

1260907-17-2sc-490339
sc-490339A
sc-490339B
sc-490339C
sc-490339D
5 mg
10 mg
50 mg
100 mg
1 g
$300.00
$540.00
$940.00
$1680.00
$5900.00
(0)

I-BET762 is another BET bromodomain inhibitor that could lead to downregulation of CPSF3 expression.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Rocaglamide inhibits translation initiation and could reduce protein levels of CPSF3.

Homoharringtonine

26833-87-4sc-202652
sc-202652A
sc-202652B
1 mg
5 mg
10 mg
$52.00
$125.00
$182.00
11
(1)

Homoharringtonine inhibits protein translation initiation, potentially decreasing CPSF3 protein levels.

Silvestrol

697235-38-4sc-507504
1 mg
$920.00
(0)

Silvestrol, a translation inhibitor, may affect CPSF3 by reducing its translation.